Myriad Genetics (MYGN) Announces Thomas P. Slavin, M.D., Named Chief Medical Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. DPZ
2. NVDA
3. DRS
4. GS
5. ACI
6. BAC
7. JPM
8. AVAV
9. UNH
10. ORCL

Go back to Myriad Genetics (MYGN) Announces Thomas P. Slavin, M.D., Named Chief Medical Officer

Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics

June 16, 2021 4:05 PM EDT

SALT LAKE CITY, June 16, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has named Thomas P. Slavin Jr. (T.J.), M.D., FACMG, DABMD, chief medical officer of the company. He will report directly to Nicole Lambert, president of Myriad Genetic Laboratories.

In his new role, Dr. Slavin will apply deep clinical and scientific expertise, combined with proven leadership and experience in precision medicine, to further elevate Myriads portfolio of genetic tests spanning oncology, womens health and... More